CLEARWATER ANALYTICS HOLDINGS INC

Company Overview

Clearwater Analytics is a cloud-native, single-instance multi-tenant SaaS provider that automates investment accounting, reporting, performance measurement, compliance monitoring, order/portfolio management and risk analytics for institutional investors and asset managers. The platform aggregated and normalized data on roughly $8.8 trillion of invested assets for ~1,400 clients as of Dec 31, 2024, with strong retention (gross ~98% and net revenue retention up to 116% in Q4 2024) and recurring, asset-based fee economics recently stabilized via a Base+ billing model. The company has prioritized heavy R&D (≈33% of revenue in 2024), machine learning/GenAI for data extraction and automation, and inorganic growth (JUMP, Wilshire, Enfusion and Beacon acquisitions) to extend front-to-back functionality and international reach.

Executive Compensation Practices

Compensation at Clearwater is likely heavily weighted toward equity and performance-based long‑term incentives given the firm’s tech/SaaS profile and the MDA disclosure of elevated equity-based compensation tied to headcount growth and acquisitions. Key payoff metrics that should drive annual and long‑term awards are ARR growth, net revenue retention, gross revenue retention, adjusted EBITDA/margin expansion and successful onboarding/integration of acquired customers and assets; AUA/aggregated assets also matter because fees are asset‑based. Management explicitly invests in R&D and acquisition integration, so PSUs or milestone awards tied to product/engineering delivery, successful cross‑sell, and retention of acquired client revenue are plausible. One-time items (TRA settlements, tax benefit realization) and material financing events (Enfusion financing) make cash/bonus design and change-in-control/retention awards around M&A more likely.

Insider Trading Considerations

Insiders at Clearwater may possess material information about client asset onboarding, large client wins/losses, or integration progress for acquisitions (Enfusion/Beacon), all of which can materially affect asset‑based fees and near‑term revenue, so trade timing around those events is sensitive. Expect common safeguards: blackout windows around quarterly results and deal closings, use of 10b5‑1 plans, and potential deal‑related retention grants that delay selling; however, elevated equity compensation and recent acquisitions may produce periodic insider sales for liquidity once vesting/blackout constraints lift. Watch for clustered insider activity around financing announcements (term loan B/revolver) or post‑close integration progress, since leverage and covenant outcomes can change investor sentiment; regulatory/data‑privacy exposures across jurisdictions also increase the likelihood of trading restrictions tied to nonpublic contractual or compliance developments.